|
About the Nitrosamines in the News category
|
|
0
|
315
|
April 14, 2021
|
|
Korean drug manufacturers are taking voluntary action by recalling or suspending the sales of tamsulosin, citing potential NDSRI impurity, N-Nitroso-tamsulosin concern
|
|
19
|
852
|
April 18, 2024
|
|
Novartis pauses some trials of cancer drug Kisqali to fix manufacturing
|
|
12
|
630
|
April 16, 2024
|
|
Nitrosamine Impurity Test Market expected to grow exponentially by 2029
|
|
0
|
420
|
November 19, 2023
|
|
Controversial but Public Report
|
|
4
|
456
|
April 6, 2024
|
|
Nitrosamines in Bacon: a Case Study of Balancing Risks
|
|
1
|
205
|
March 20, 2024
|
|
NEWS! New USP Community on qNMR
|
|
0
|
199
|
March 1, 2024
|
|
Quality Officer Call for a New approach to Reduce Post Approval Complexity
|
|
0
|
233
|
February 28, 2024
|
|
๐ฐ Nitrosamine measures might disrupt anesthetic supply, Dr. Eric Tichy says
|
|
4
|
369
|
January 26, 2024
|
|
FDA leaders detail reorg plans Webinar
|
|
0
|
207
|
January 23, 2024
|
|
๐ช๐บ Ph. Eur. Commission adopts revised general monographs 2034 and 2619 after inclusion of new paragraph on control of N-nitrosamines
|
|
1
|
787
|
January 22, 2024
|
|
US FDA- Generic Drug Science and Research Priority Initiatives for Fiscal Year (FY) 2024
|
|
0
|
279
|
January 18, 2024
|
|
Reflective Beginnings: We have to be in the driver's seat
|
|
4
|
451
|
January 9, 2024
|
|
๐จโ๐ป Nitrosamines Trends in Google
|
|
0
|
341
|
January 8, 2024
|
|
๐ Happy Holiday and a Nitrosamines-free 2024!
|
|
8
|
686
|
January 7, 2024
|
|
ISP (Chile) announced the voluntary market withdrawal of Atomoxetine DP (40mg & 80mg) due presence of Nitroso-Atomoxetine
|
|
5
|
1076
|
December 14, 2023
|
|
4000 Members Milestone ๐
|
|
18
|
711
|
November 3, 2023
|
|
ๅ
ณไบ2023่ฏ็ฉๆ่ดจๆงๅถๅฝ้
ไบคๆตไผ็่ต่ฎฏ
|
|
1
|
374
|
September 29, 2023
|
|
Singapore: HSA issues retail-level recalls for batches of Apo-Amitriptyline and Apo-Acyclovir tablets due to nitrosamine impurity concerns
|
|
0
|
436
|
September 4, 2023
|
|
Apotex Inc. Canada is recalling one lot of APO-Amitriptyline due to presence of nitrosamine impurity, N-nitrosodimethylamine (NDMA) above the acceptable limit at the 48-month stability testing timepoint
|
|
15
|
1217
|
September 3, 2023
|
|
Fluoxetin Recall - Austria
|
|
6
|
582
|
July 28, 2023
|
|
European Pharmacopoeia Commission revises position on nitrosamine impurities
|
|
2
|
555
|
July 28, 2023
|
|
๐ง๐ท ANVISA (Brasil) denies registration
|
|
0
|
427
|
July 27, 2023
|
|
Pharmaceutical industry wants FDA to extend deadline for testing novel nitrosamines
|
|
3
|
746
|
July 21, 2023
|
|
๐ Aripiprazole is not approvable since 'major objections' have been identified
|
|
6
|
646
|
July 18, 2023
|
|
๐จ๐ญ Swissmedic creates nitrosamine expert group to coordinate with manufacturers, regulators
|
|
2
|
476
|
July 10, 2023
|
|
Phathom Pharmaceuticals reported that it has detected trace levels of a nitrosamine impurity in their vonoprazan-based products (may be NDSRI, nitroso-Vonoprazan ? ) that is not described within the FDA Nitrosamine guidance document
|
|
16
|
2172
|
June 26, 2023
|
|
Ministry of Food and Drug Safety of the Republic of Korea detected N-Nitroso-Atenolol in atenolol formulation products
|
|
5
|
922
|
May 7, 2023
|
|
The Great Nitrosamine Audit: how many more drugs will disappear from our shelves?
|
|
2
|
699
|
April 26, 2023
|
|
Nitrosamine in Antabuse
|
|
7
|
869
|
April 18, 2023
|